These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11011010)

  • 1. Enhancement of the acoustic startle response by dopamine agonists after 6-hydroxydopamine lesions of the substantia nigra pars compacta: corresponding changes in c-Fos expression in the caudate-putamen.
    Meloni EG; Davis M
    Brain Res; 2000 Oct; 879(1-2):93-104. PubMed ID: 11011010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C; Kirik D; Björklund A; Cenci MA
    Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
    Fenu S; Pinna A; Ongini E; Morelli M
    Eur J Pharmacol; 1997 Feb; 321(2):143-7. PubMed ID: 9063681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats.
    Haberny SL; Carr KD
    Brain Res Mol Brain Res; 2005 Nov; 141(2):121-7. PubMed ID: 16257473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of the acoustic startle reflex by dopamine D1 and 5-HT1A agonists and corresponding changes in c-Fos expression in the dorsal raphe of rats.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 2000 Sep; 151(4):359-67. PubMed ID: 11026743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Hassani OK; Féger J
    Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA in the deep layers of the superior Colliculus/Mesencephalic reticular formation mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
    Meloni EG; Davis M
    J Neurosci; 2000 Jul; 20(14):5374-81. PubMed ID: 10884322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 2004 Jul; 174(2):228-36. PubMed ID: 14735289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Svenningsson P; Gunne L; Andren PE
    Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
    Morelli M; Fenu S; Pinna A; Di Chiara G
    J Pharmacol Exp Ther; 1992 Jan; 260(1):402-8. PubMed ID: 1346165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat.
    Rushlow WJ; Rajakumar B; Flumerfelt BA; Naus CC; Rajakumar N
    Neuroscience; 2000; 98(1):69-78. PubMed ID: 10858613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.